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Introduction ͶͲ
Legionella pneumophila is a Gram-negative bacterium found ubiquitously in environmental Ͷͳ
water reservoirs where it replicates in free-living protozoa (38). Following inhalation of Ͷʹ
contaminated aerosols, L. pneumophila is capable of infecting human alveolar macrophages Ͷ͵
and causing disease ranging from mild flu-like symptoms to Legionnaires’ disease, a severe, ͶͶ
life-threatening pneumonia (16). L. pneumophila thrives in professional phagocytes by Ͷͷ
avoiding killing by the phago-lysosomal pathway (21). Instead it establishes a specialized Ͷ͸
Legionella containing vacuole (LCV), which shows characteristics of the rough endoplasmic Ͷ͹
reticulum (ER) (48). Ͷͺ
L. pneumophila employs several specialized protein secretion systems, e.g. the twin-arginine Ͷͻ
translocation (Tat) pathway and a type II secretion system (T2SS), to secrete virulence ͷͲ
factors, some of which have been shown to contribute to Legionella’s intracellular survival ͷͳ
and pathogenicity (11, 12). However, the essential virulence determinant of L. pneumophila ͷʹ
is the Dot (defective in organelle trafcking)/Icm (intracellular multiplication) type IV ͷ͵
secretion system (T4SS), which is indispensable for intracellular survival and establishment ͷͶ
of the replication-permissive LCV in both amoebae and macrophages (4, 45). The Dot/Icm ͷͷ
T4SS is a multi-protein complex able to translocate at least 275 effector proteins directly into ͷ͸
host cells (35, 53). Although it has been demonstrated that several T4SS effectors manipulate ͷ͹
host cell vesicular trafficking, inhibit apoptosis and immune signaling, the function of the ͷͺ
majority of T4SS effectors during infection is still unknown (5). ͷͻ
Free-living freshwater amoebae such as Acanthamoeba castellanii or Hartmannella ͸Ͳ
vermiformis routinely serve as model hosts to study molecular aspects of Legionella ͸ͳ
pathogenesis (1, 20). As natural hosts, these professional phagocytes are believed to have ͸ʹ
exerted evolutionary pressure for the selection of Legionella’s virulence factors that enable ͸͵
the bacteria to overcome the antimicrobial activities of human macrophages (32). In addition, ͸Ͷ
 Ͷ
Dictyostelium discoideum has become a prevalent protozoan model organism as it can readily ͸ͷ
be genetically modified (47). Although, protozoan Legionella infection models have proven ͸͸
successful, they do not fully reflect the infection of macrophages as amoeba employ less ͸͹
complex antimicrobial mechanisms than mammalian cells.  ͸ͺ
The nematode Caenorhabditis elegans possesses an innate immune system and is a well-͸ͻ
established model for several bacterial pathogens including Legionella spp. (5). However, ͹Ͳ
one caveat to the use of C. elegans is that bacteria replicate in the intestinal lumen and do not ͹ͳ
invade intestinal epithelial cells, limiting the usefulness of this model to study virulence ͹ʹ
determinants required for Legionella’s intracellular lifestyle.  ͹͵
Typically, human Legionella infection is modeled using mammalian hosts (3, 6). Disease ͹Ͷ
progression in the guinea pig resembles Legionellosis in humans and pathology includes ͹ͷ
lymphocyte infiltration, goblet cell metaplasia, mild fibrosis and emphysema (3). In contrast, ͹͸
the majority of mouse strains are resistant to Legionella infection (52) with the exception of ͹͹
the inbred albino A/J mouse, which develops a self-limiting infection (6). ͹ͺ
Due to the high cost and ethical considerations associated with the use of mammalian hosts, ͹ͻ
the search for alternative models is ongoing. Insect model organisms, in particular ͺͲ
Drosophila melanogaster, have been introduced to study bacterial pathogenesis (44). L. ͺͳ
pneumophila replicates in D. melanogaster and kills the flies in a Dot/Icm T4SS-dependent ͺʹ
manner (27). The human and insect innate immune systems demonstrate many similarities ͺ͵
(24, 29) with most insect species containing specialized cells known as haemocytes that ͺͶ
phagocytose pathogens and form aggregates which encapsulate and neutralize foreign ͺͷ
microorganisms (30). Moreover, activated haemocytes can trigger a phenoloxidase (PO) ͺ͸
melanisation cascade leading to physical restriction of intruders and the production of ͺ͹
antimicrobial compounds (8). Haemocyte-mediated responses are complemented by the ͺͺ
 ͷ
production and secretion of anti-microbial peptides by the insect fat body, an organ similar to ͺͻ
the mammalian liver (29, 31). ͻͲ
Besides D. melanogaster, the larva of the greater wax moth Galleria mellonella has become a ͻͳ
widely adopted insect model to study a wide range of human pathogens including Listeria ͻʹ
spp. (23), Streptococcus pyogenes (36), Campylobacter jejuni (10), Yersinia ͻ͵
pseudotuberculosis (9) and several pathogenic fungi (17, 33). G. mellonella larvae can be ͻͶ
easily maintained and infected by injection without anesthesia and sustain incubation at 37C ͻͷ
(33). A good correlation between the pathogenicity of several microorganisms in G. ͻ͸
mellonella and other mammalian models of infection has been established (22, 23). The aim ͻ͹
of this study was to determine if G. mellonella could be used as a model to study L. ͻͺ
pneumophila pathogenesis. ͻͻ
 ͸
Material and Methods ͳͲͲ
Bacterial strains and G. mellonella larvae. L. pneumophila serogroup 1 strain 130b is a ͳͲͳ
spectinomycin-resistant clinical isolate from the Wadsworth Veterans Administration ͳͲʹ
Hospital, Los Angeles, CA (14). The L. pneumophila ∆DotA strain is a dotA insertion mutant ͳͲ͵
(kanamycin resistance) of L. pneumophila strain 130b (41). L. pneumophila strain JR32 is a ͳͲͶ
salt sensitive streptomycin-resistant L. pneumophila strain Philadelphia-1 isolate (39) and the ͳͲͷ
∆IcmT strain is an icmT isogenic mutant in the JR32 strain (46). L. pneumophila strain Lp02 ͳͲ͸
is a thymine auxotroph streptomycin-resistant derivative of the Philadelphia-1 strain (4). L. ͳͲ͹
pneumophila strain Paris is a worldwide epidemic strain (7) G. mellonella larvae were ͳͲͺ
obtained from Livefoods, UK and stored at room temperature in the dark. ͳͲͻ
Infection of G. mellonella. L. pneumophila strains were cultured on charcoal-yeast extract ͳͳͲ
(CYE) plates for four days then inoculated into ACES yeast extract (AYE) as described ͳͳͳ
previously (43). For the Lp02 strain, thymidine (100 µg/ml) was added. After 21 h of growth, ͳͳʹ
bacteria were diluted in Dulbecco’s phosphate buffered saline (PBS) to an OD600 of 1 which ͳͳ͵
corresponds to 109 CFU/ml unless otherwise indicated. Gene expression in strains containing ͳͳͶ
the p4HA plasmid was additionally induced during infection with 1mM isopropyl ȕ-d-1-ͳͳͷ
thiogalactopyranoside (IPTG). Ten G. mellonella larvae were injected with 10 µl of bacterial ͳͳ͸
suspension as previously described (37) and were incubated at 37C in the dark. As a control ͳͳ͹
ten larvae were injected with PBS alone and ten untreated insects were included with every ͳͳͺ
experiment. Larvae were individually examined for pigmentation and time of death was ͳͳͻ
recorded. Assays were only allowed to proceed for 3 days as pupa formation could ͳʹͲ
occasionally be seen by day 4. At least three independent replicates of each experiment were ͳʹͳ
performed.  ͳʹʹ
 ͹
Intracellular growth assay. At 0, 2, 5, 18 and 24 h post infection (p. i.) haemolymph was ͳʹ͵
extracted from three infected larvae and pooled as previously described (23). Cells were ͳʹͶ
lysed by incubation of the haemolymph with 1 µl of 5 mg/ml digitonin for 5 min at room ͳʹͷ
temperature. Extracted haemolymph was serially diluted in AYE media and plated onto CYE ͳʹ͸
plates. To prevent contamination, the extracted haemolymph was plated on CYE plates ͳʹ͹
supplemented with spectinomycin (50 µg/ml) for the L. pneumophila strain 130b or ͳʹͺ
streptomycin (100 µg/ml) for the Philadelphia-1-derived strains. Plates were incubated at 37 ͳʹͻ
C for three days, viable bacteria were enumerated and the number of CFU was normalized to ͳ͵Ͳ
the weight of haemolymph extracted.  ͳ͵ͳ
Plasmids. A fragment of the SidC homologue from L. pneumophila 130b containing the ͳ͵ʹ
phosphatidylinositol-4 phosphate binding domain (amino acids 41 to 918) was cloned into ͳ͵͵
the Xbal and BamHI sites of the p4HA plasmid (13) to yield the IPTG-inducible 4HA-SidC41-ͳ͵Ͷ
918 expression plasmid pICC562  using the forward primer 5’-ͳ͵ͷ
cgtattctagataacacctgccaaacagcagttgag-3’ and the reverse primer 5’-ͳ͵͸
ggctaggatccctatttctttataactcccgtgtac-3’ and standard molecular biology techniques. ͳ͵͹
Indirect immunofluorescence on extracted haemocytes. Haemolymph from infected G. ͳ͵ͺ
mellonella was extracted at 5 and 24 h post infection. The extracted haemolymph was ͳ͵ͻ
dispensed onto poly-L-lysine coated glass coverslips and centrifuged at 500 x g for 10 min to ͳͶͲ
allow sedimentation and attachment of haemocytes. Coverslips were washed twice with PBS ͳͶͳ
and fixed using 4% paraformaldehyde for 20 min followed by quenching with 50 mM ͳͶʹ
ammonium chloride. Extracellular L. pneumophila were stained with a mouse anti-L. ͳͶ͵
pneumophila LPS antibody (ViroStat) and a donkey anti-mouse Rhodamine Red-X-ͳͶͶ
conjugated antibody (Jackson ImmunoResearch Laboratories, Inc.). After permeabilization of ͳͶͷ
the cells with 0.1% Triton in PBS and blocking with 2% (w/v) bovine serum albumin (BSA) ͳͶ͸
in PBS, total bacteria were stained with a rabbit anti-L. pneumophila antibody (Affinity ͳͶ͹
 ͺ
BioReagents) and a donkey anti-rabbit Alexa Fluor 488-conjugated antibody (Jackson ͳͶͺ
ImmunoResearch).  ͳͶͻ
To visualize 4HA-SidC41-918 in haemocytes, fixed cells were permeabilised and blocked for 1 ͳͷͲ
h in PBS containing 2% (w/v) BSA. Samples were stained with rabbit anti-L. pneumophila ͳͷͳ
antibody (Affinity BioReagents), donkey anti-rabbit Alexa Fluor 488-conjugated antibody ͳͷʹ
(Jackson ImmunoResearch), mouse anti-HA conjugated to Tetramethyl Rhodamine Iso-ͳͷ͵
Thiocyanate (TRITC) (Sigma) and 5 µg mlí1 of 4ƍ,6-diamidino-2-phenylindole (DAPI) to ͳͷͶ
visualize DNA. Samples were analyzed using an Axio M1 Imager microscope and images ͳͷͷ
processed with the AxioVision software (Carl Zeiss). ͳͷ͸
Staining of formalin fixed sections of G. mellonella. G. mellonella were fixed in formalin ͳͷ͹
for one week at room temperature, paraffin embedded, sectioned and stained either with ͳͷͺ
haematoxylin and eosin (H&E) or by indirect immunofluorescence as described previously ͳͷͻ
(18). L. pneumophila was stained with rabbit anti-L. pneumophila antibody (Affinity ͳ͸Ͳ
BioReagents) and donkey anti-rabbit Alexa Fluor 488-conjugated antibody (Jackson ͳ͸ͳ
ImmunoResearch). Cellular and bacterial DNA was stained with DAPI and the shape of the ͳ͸ʹ
tissues was visualized using Rhodamine Phalloidin (Invitrogen). ͳ͸͵
Transmission electron microscopy. Haemolymph was extracted from ten infected G. ͳ͸Ͷ
mellonella per condition and time point. Cells were spun down onto 6 well plates, washed ͳ͸ͷ
once with PBS and fixed in 2% glutaraldehyde. Samples were processed as described ͳ͸͸
previously (26) and examined using a Tecnai12 (FEI) electron microscope. Images were ͳ͸͹
taken with a CCD camera (TVIPS, Gauting, Germany). ͳ͸ͺ
Haemocyte quantification and viability assay. Infected haemolymph was extracted at 5 and ͳ͸ͻ
18 h p.i., Trypan blue (0.02% (v/v) in PBS) was added to cells and incubated at room ͳ͹Ͳ
temperature for 10 min. Viable cells were enumerated using a haemocytometer and each ͳ͹ͳ
 ͻ
sample was analysed in triplicate. The average of three independent experiments was plotted ͳ͹ʹ
graphically. ͳ͹͵
Phenoloxidase (PO) activity assay. At 5 and 18 h p.i. haemolymph from three infected ͳ͹Ͷ
insects per condition was extracted and pooled. Cells and debris were removed by ͳ͹ͷ
centrifugation at 20000 x g for 10 min at 4 C. The phenoloxidase activity in the plasma was ͳ͹͸
quantified using a microplate enzyme assay as described previously (15). The change in ͳ͹͹
absorbance at 490 nm was read for 1 h at room temperature with a reading taken every ͳ͹ͺ
minute using a Fluostar Optima plate reader (BMG labtech, Germany). The experiment was ͳ͹ͻ
performed in triplicate and independently repeated at least three times. Phenoloxidase activity ͳͺͲ
was expressed as the mean OD490/minute. ͳͺͳ
RNA extraction and RT-PCR. At indicated time points fat bodies from three larvae were ͳͺʹ
collected and stored in RNAlater (Qiagen) at 4 C until processing. Tissue was homogenized ͳͺ͵
by a gentleMACS homogeniser (Miltenyi Biotech) using M tubes and the 90 s RNA setting. ͳͺͶ
RNA was extracted using a RNAeasy kit (Qiagen) and contaminating DNA was digested ͳͺͷ
using Turbo DNA-free kit (Ambion) following the manufacturer's instructions. Two-step RT-ͳͺ͸
PCR was performed using Superscript reverse transcriptase (Invitrogen) using 2 µg of RNA ͳͺ͹
as a template and random hexamers (Invitrogen). Genes were amplified using RedTaq ͳͺͺ
readymix (Sigma) and 0.6 pM of gene specific primers (Table 1) as described previously (23). ͳͺͻ
DNA was analyzed on a 1% agarose gel with SYBRSafe (Invitrogen) and quantified using ͳͻͲ
ImageJ software (NIH).  ͳͻͳ
 ͳͲ
Results ͳͻʹ
 ͳͻ͵
L. pneumophila infection causes death of Galleria mellonella larvae ͳͻͶ
In order to investigate the pathogenicity of L. pneumophila in G. mellonella larvae, we used ͳͻͷ
three serogroup 1 L. pneumophila strains: 130b, Paris and JR32, which are commonly used ͳͻ͸
for molecular pathogenesis studies. The bacteria were injected into the larvae and their ͳͻ͹
survival monitored over 72 h (Fig. 1A). All three L. pneumophila strains caused time-ͳͻͺ
dependent death of at least 70% of the G. mellonella; strain 130b caused significantly ͳͻͻ
(P<0.005) higher mortality than the JR32 or Paris strains at 18 h p.i. No mortality was ʹͲͲ
observed in the control buffer-injected G. mellonella. These results demonstrate that G. ʹͲͳ
mellonella is susceptible to L. pneumophila infection. ʹͲʹ
 ʹͲ͵
Mortality in L. pneumophila-infected G. mellonella is dose-dependent  ʹͲͶ
To determine if the mortality caused by L. pneumophila infection was dependent on the ʹͲͷ
number of injected bacteria, G. mellonella were injected with 104, 105 106 or 107 CFU of L. ʹͲ͸
pneumophila strain 130b. While infection with 107 CFU resulted in 100% G. mellonella ʹͲ͹
mortality within 24 h of infection, mortality was reduced to less than 40% in larvae injected ʹͲͺ
with 106 CFU, and no mortality was observed in G. mellonella injected with any of the lower ʹͲͻ
doses (104 and 105 CFU) (Fig. 1B). These results show that L. pneumophila induces dose ʹͳͲ
dependent G. mellonella mortality. ʹͳͳ
 ʹͳʹ
The growth phase of L. pneumophila influences the kinetics of G. mellonella mortality ʹͳ͵
During its lifecycle, L. pneumophila alternates between replicative and transmissive forms ʹͳͶ
(19). A number of virulence factors that promote infection of new host cells are down-ʹͳͷ
regulated in the replicative phase and up-regulated in the transmissive phase. In broth culture, ʹͳ͸
 ͳͳ
the transmissive traits are repressed in the exponential phase and expressed as the bacteria ʹͳ͹
enter the post-exponential phase (19). In order to assess if expression of the transmissive ʹͳͺ
traits were important to induce G. mellonella mortality, insects were inoculated with 107 CFU ʹͳͻ
L. pneumophila 130b cultured to exponential (OD600~0.4), post-exponential (OD600~3) or ʹʹͲ
stationary (OD600>4) phases. Over the entire time course, significantly more (P<0.0005 at 18 ʹʹͳ
h p.i.) larvae injected with exponential and stationary phase bacteria survived than the ones ʹʹʹ
inoculated with post-exponential phase bacteria (Fig. 1C). This indicates that the growth ʹʹ͵
phase of L. pneumophila influences virulence in the G. mellonella model. ʹʹͶ
 ʹʹͷ
The L. pneumophila Dot/Icm T4SS is essential for G. mellonella infection ʹʹ͸
The Dot/Icm T4SS of L. pneumophila is essential for intracellular survival and the ʹʹ͹
establishment of a replicative vacuole (4, 45). The 130b ∆DotA strain has a kanamycin ʹʹͺ
resistance cassette inserted in the dotA gene resulting in a non-functional T4SS (43). ʹʹͻ
Infection of G. mellonella with 107 CFU 130b ∆DotA did not cause any mortality of the ʹ͵Ͳ
larvae over the three days of the experiment, whereas the parental wild type strain killed all ʹ͵ͳ
larvae within 24 h (Fig. 1D). This demonstrated that L. pneumophila-induced mortality of G. ʹ͵ʹ
mellonella is dependent on the presence of a functional Dot/Icm T4SS.  ʹ͵͵
 ʹ͵Ͷ
G. mellonella mortality depends on L. pneumophila persistence ʹ͵ͷ
In order to determine the viable bacterial load within the haemolymph of G. mellonella ʹ͵͸
infected with L. pneumophila, larvae were injected with 107 CFU wild type or ∆DotA 130b. ʹ͵͹
At selected time points, haemolymph from three living larvae was extracted, pooled and the ʹ͵ͺ
number of CFU/100 µl of extracted haemolymph was determined (Fig. 2A). The 130b ʹ͵ͻ
∆DotA mutant was cleared from the injected larvae by 24 h p.i. and did not exhibit any ʹͶͲ
replication. On the contrary, infection of G. mellonella with wild type 130b resulted in an ʹͶͳ
 ͳʹ
initial 10-fold reduction of CFU 5 h p.i., but the bacterial numbers then increased up to 100-ʹͶʹ
fold from the inoculum until 24 h p.i., demonstrating that L. pneumophila is able to replicate ʹͶ͵
in G. mellonella. ʹͶͶ
To   L. pneumophila      haemolymph, ʹͶͷ
haemocytes were extracted from infected G. mellonella at 5 and 24 h p.i. and immuno-stained ʹͶ͸
for external and total bacteria (Fig. 2B). By 5 h p.i. both wild type and ∆DotA 130b were ʹͶ͹
found inside (green bacteria) and attached to (yellow bacteria) haemocytes. By 24 h p.i. ʹͶͺ
haemocytes extracted from G. mellonella infected with wild type bacteria were full of ʹͶͻ
intracellular L. pneumophila, whereas no bacteria could be found in haemocytes of G. ʹͷͲ
mellonella infected with the 130b ∆DotA strain (data not shown). This result indicates that L. ʹͷͳ
pneumophila replicates in G. mellonella haemocytes. ʹͷʹ
In order to determine the impact of L. pneumophila persistence and intracellular replication ʹͷ͵
on G. mellonella mortality, we tested two closely related strains derived from the L. ʹͷͶ
pneumophila strain Philadelphia-1, JR32 and Lp02 with JR32 ǻIcmT as a T4SS-deficient ʹͷͷ
control. While both JR32 and Lp02 encode a functional Dot/Icm T4SS, the latter is a thymine ʹͷ͸
auxotroph showing reduced intracellular survival and replication in cultured cells in the ʹͷ͹
absence of added thymine or thymidine (4). Quantification of the CFU extracted from the ʹͷͺ
haemolymph over 24 h (Fig. 2C) showed that the JR32 persisted in injected G. mellonella ʹͷͻ
throughout the infection, while the JR32 ∆IcmT strain, which does not have a functional ʹ͸Ͳ
T4SS, was cleared within 18 h. The Lp02 strain persisted to higher CFU than the JR32 ʹ͸ͳ
∆IcmT strain 18 h p.i., before ultimately cleared by 24 h p.i. While JR32 killed all the ʹ͸ʹ
infected insects, both the Lp02 and JR32 ǻIcmT strains were unable to cause death in ʹ͸͵
injected G. mellonella over three days p.i., (Fig. 2D). These data indicate that a functional ʹ͸Ͷ
T4SS which enables the Lp02 strain to translocate effectors during the first hours of infection ʹ͸ͷ
(Fig. 4) is not sufficient to induce death of the larvae. The mortality of L. pneumophila-ʹ͸͸
 ͳ͵
injected G. mellonella depends therefore on both the T4SS and the ability of the bacteria to ʹ͸͹
persist within the larvae for more then 18 h.  ʹ͸ͺ
 ʹ͸ͻ
L. pneumophila resides in a LCV in haemocytes  ʹ͹Ͳ
In order to assess if L. pneumophila forms a LCV in haemocytes, we analyzed haemocytes ʹ͹ͳ
from infected G. mellonella by transmission electron microscopy (TEM) (Fig. 3). By 5 h p.i L. ʹ͹ʹ
pneumophila 130b was observed within distinct vacuoles, which were associated with ʹ͹͵
mitochondria and ribosomes. As the infection progressed, more bacteria could be seen within ʹ͹Ͷ
the LCV until the majority of haemocytes were filled with bacteria. By 24 h p.i. the LCV was ʹ͹ͷ
studded with ribosomes. L. pneumophila therefore appears to reside in haemocytes of ʹ͹͸
infected G. mellonella in LCVs, which are similar to those seen in human monocytes (21).  ʹ͹͹
To further characterize the LCVs formed in haemocytes, we evaluated the recruitment of ʹ͹ͺ
SidC, a T4SS L. pneumophila effector previously shown to bind the LCV membrane through ʹ͹ͻ
interaction with phosphatidylinositol-4 phosphate (PI4P) (51). A 4HA epitope-tagged SidC41-ʹͺͲ
918 was expressed in L. pneumophila and the localization of the protein was analyzed by ʹͺͳ
immunofluorescence (Fig. 4). To ensure the protein was expressed, larvae were injected with ʹͺʹ
bacterial suspension containing 1 ȝM IPTG. The presence of IPTG alone did not affect ʹͺ͵
survival (data not shown). Similarly to human A549 cells (data not shown), anti-HA staining ʹͺͶ
of SidC41-918 surrounded intracellular bacteria in haemocytes. No anti-HA staining was ʹͺͷ
observed in the control haemocytes extracted from larvae infected with L. pneumophila 130b ʹͺ͸
∆DotA expressing 4HA-SidC41-918. At 24 h p.i. haemocytes from G. mellonella infected with ʹͺ͹
wild type 130b were full of bacteria surrounded by 4HA-SidC41-918-stained LCVs. Similar ʹͺͺ
results were obtained with the thymine prototroph strain JR32. In accordance with the results ʹͺͻ
presented in Fig. 2C, the thymine auxotroph strain Lp02 did not show evidence of replication ʹͻͲ
24 h p.i. yet it displayed recruitment of 4HA-SidC41-918 to the LCV membrane at both 5 and ʹͻͳ
 ͳͶ
24 h p.i. These results indicate that similar to infection of protozoan or mammalian host cells, ʹͻʹ
L. pneumophila is able to translocate a T4SS-substrate and to form an LCV in G. mellonella ʹͻ͵
haemocytes. ʹͻͶ
 ʹͻͷ
G. mellonella pathology in response to L. pneumophila infection ʹͻ͸
In order to examine the effect of L. pneumophila infection on G. mellonella physiology, the ʹͻ͹
infected larvae were fixed and paraffin embedded sections were stained with haematoxylin ʹͻͺ
and eosin (H&E) and evaluated for histological changes (Fig. 5). Mock-infected controls ʹͻͻ
appeared healthy with no bacteria observed in the haemocoel and individually distributed ͵ͲͲ
haemocytes occasionally forming loose aggregations. However, in both wild type and ͵Ͳͳ
∆DotA-infected insects, vigorous host defenses appeared to be mounted. At 16 h p.i. with ͵Ͳʹ
130b ∆DotA, fewer individual haemocytes were observed compared to the mock infected ͵Ͳ͵
control, with the majority of haemocytes present in tightly packed aggregation nodules and ͵ͲͶ
some evidence of melanisation. By 24 h p.i. we observed similar features, but the majority of ͵Ͳͷ
the tissue looked healthy. In larvae infected with wild type bacteria at 16 h p.i. haemocytes ͵Ͳ͸
were observed in nodules attached to organ structures, with clearly visible nodule ͵Ͳ͹
melanisation. By 24 h p.i. nodules were still observed however septicemia was found in much ͵Ͳͺ
of the haemocoel and organ structures including the gut appeared severely damaged. ͵Ͳͻ
In order to confirm that the bacteria observed in formalin fixed sections of the infected G. ͵ͳͲ
mellonella were L. pneumophila, sections were stained using a specific anti-L. pneumophila ͵ͳͳ
antibody. DNA was visualized by DAPI staining and the tissue structure was counter strained ͵ͳʹ
using rhodamine-conjugated phalloidin (Fig. 6). Anti-L. pneumophila antibodies did not stain ͵ͳ͵
any bacteria in the uninfected or 130b ∆DotA infected insects at 18 h p.i. In the G. mellonella ͵ͳͶ
infected with wild type 130b, bacteria stained with the anti-L. pneumophila antibody were ͵ͳͷ
found throughout the haemolymph (Fig. 6) and occasionally in cells within the fat bodies (not ͵ͳ͸
 ͳͷ
shown). Bacteria were exclusively associated with cells and were usually found in aggregates ͵ͳ͹
of haemocytes.  ͵ͳͺ
Altogether, these data indicate that L. pneumophila triggers an immune response in G. ͵ͳͻ
mellonella that successfully clears the ∆DotA mutant from the larvae, whereas wild type L. ͵ʹͲ
pneumophila are resistant to host defenses. ͵ʹͳ
 ͵ʹʹ
The G. mellonella immune responses to L. pneumophila infection ͵ʹ͵
Progression of L. pneumophila infection resulted in an increase in G. mellonella pigmentation ͵ʹͶ
(Fig. 7A), which is usually indicative of activation of the PO. Upon recognition of pathogen ͵ʹͷ
associated molecular patterns (PAMPs), the pro-PO system components are released from ͵ʹ͸
haemocytes into the haemolymph, leading to activation of PO. The activity of this enzyme ͵ʹ͹
subsequently induces the formation of quinones and melanin, which are involved in defense ͵ʹͺ
reactions against pathogens invading the haemocoel, such as nodule formation and ͵ʹͻ
encapsulation (8). In order to quantify this innate immune response, we assayed at selected ͵͵Ͳ
time points the level of PO activity in the haemolymph of G. mellonella infected with 130b ͵͵ͳ
(Fig. 7B). By 5 h p.i. insects injected with wild type L. pneumophila exhibited dramatically ͵͵ʹ
increased PO activity compared to larvae injected with PBS (P<0.005). Larvae inoculated ͵͵͵
with L. pneumophila ǻDotA presented an intermediate level of PO activity. By 18 h p.i. the ͵͵Ͷ
level of PO activity did not significantly change in the PBS and 130b ∆DotA injected G. ͵͵ͷ
mellonella. However in G. mellonella injected with wild type bacteria, levels of PO activity ͵͵͸
significantly dropped compared to 5 h p.i. (P<0.005), reaching levels similar to the PBS ͵͵͹
control. These results indicate that L. pneumophila infection initiates an immune defense in G. ͵͵ͺ
mellonella through PO activation, a response which is nonetheless abrogated by 18 h p.i. ͵͵ͻ
In order to test if the absence of PO activity at 18 h p.i. could be due to haemocyte depletion, ͵ͶͲ
insects were infected with wild type or ∆DotA 130b, or injected with PBS as a control and ͵Ͷͳ
 ͳ͸
haemocytes were counted by light microscopy at 5 and 18 h p.i. (Fig. 7C). At 5 h p.i. the ͵Ͷʹ
concentration of haemocytes per ml of haemoplymph was comparable in the different groups. ͵Ͷ͵
However, by 18 h p.i. the number of haemocytes was reduced by almost 90% in G. ͵ͶͶ
mellonella inoculated with wild type 130b as compared to 5 h p.i. or the controls, suggesting ͵Ͷͷ
that L. pneumophila infection induces haemocyte destruction. The reduction in haemocyte ͵Ͷ͸
number observed is likely to contribute to the decreased PO activation observed 18 h p.i. ͵Ͷ͹
A major component of the defense response of insects is the production of antimicrobial ͵Ͷͺ
peptides (AMP) (29, 31). In order to assess if G. mellonella produced AMPs following L. ͵Ͷͻ
pneumophila infection, their expression was tested in fat bodies, where they are mainly ͵ͷͲ
produced. Semi-quantitative RT-PCR on extracted mRNA showed that infection with wild ͵ͷͳ
type L. pneumophila resulted in an up-regulation of most of the immune-related peptides ͵ͷʹ
tested compared to a PBS-injected control (Fig. 8), with a significantly increased expression ͵ͷ͵
of gloverin and pro-PO (PPO) as soon as 2 h p.i. (P<0.006). In contrast, gallerimycin, ͵ͷͶ
galliomycin and the iron binding protein transferrin were significantly up-regulated only after ͵ͷͷ
18 h of infection (P<0.0005 for gallerimycin and transferrin and P<0.005 for galliomycin). ͵ͷ͸
The expression of the peptidoglycan recognition protein B (PRPB) did not significantly ͵ͷ͹
increase upon inoculation with wild type L. pneumophila. Injection with ∆DotA did not cause ͵ͷͺ
significant change from the baseline level with the exception of the AMP gloverin, the ͵ͷͻ
mRNA level of which increased after 24 h (P<0.01). These results show that G. mellonella ͵͸Ͳ
mounts an immune response to L. pneumophila infection that nonetheless is not effective in ͵͸ͳ
clearing the wild type bacteria. ͵͸ʹ
 ͳ͹
Discussion ͵͸͵
Adequate infection models that approximate human disease are the key to analyze the ͵͸Ͷ
molecular basis of bacterial pathogenesis. Substantial advances in our knowledge about their ͵͸ͷ
genetics and immune responses have led to the increased use of insects as surrogate hosts. In ͵͸͸
particular, the larvae of the greater wax moth Galleria mellonella have recently been reported ͵͸͹
as easy-to-use model organism for several pathogenic Gram-positive and Gram-negative ͵͸ͺ
bacteria (23, 36). These studies demonstrated a good correlation between the G. mellonella ͵͸ͻ
and mammalian infection models (10, 23, 36).  In this study we characterized G. mellonella ͵͹Ͳ
as new infection model for L. pneumophila.  ͵͹ͳ
Using three prototypic L. pneumophila strains, we found that G. mellonella could withstand a ͵͹ʹ
low infectious dose but the larvae succumbed to infection with higher doses. At the highest ͵͹͵
dose all three tested strains caused substantial death of the larvae; however the kinetics of ͵͹Ͷ
lethality differed with L. pneumophila strain 130b being more virulent than strains JR32 and ͵͹ͷ
Paris. Although a systematic comparison of the virulence phenotypes of all the three strains ͵͹͸
in amoeba or mammalian models has not been reported, strain 130b was previously shown to ͵͹͹
replicate more efficiently than JR32 following intra-tracheal infection of A/J mice (40). In a ͵͹ͺ
comparative assessment of the virulence traits of 27 L. pneumophila and non-pneumophila ͵͹ͻ
strains, 130b was the third-most cytopathogenic strain (2). Taken together this indicates that ͵ͺͲ
the G. mellonella model can reproduce strain-to-strain variations in virulence observed in ͵ͺͳ
mammalian cell culture and animal models, which makes it a quick and inexpensive tool to ͵ͺʹ
compare the virulence of different L. pneumophila isolates or Legionella species. ͵ͺ͵
The Dot/Icm T4SS of L. pneumophila is essential for infection of amoeba, human ͵ͺͶ
macrophages, mice, and D. melanogaster (4, 27, 42, 45). The D. melanogaster model has ͵ͺͷ
been successfully used to demonstrate the contribution of the Dot/Icm effector LubX to L. ͵ͺ͸
pneumophila replication and fly lethality. We found that L. pneumophila-induced mortality of ͵ͺ͹
 ͳͺ
G. mellonella also depended on a functional Dot/Icm T4SS. A T4SS-deficient mutant did not ͵ͺͺ
show any virulence even at the highest (107 CFU) inoculum injected. This contrasts ͵ͺͻ
observations described for the G. mellonella model of Listeria infection, in which ͵ͻͲ
nonpathogenic strains with increasing doses up to 107 CFU per larvae also induced mortality ͵ͻͳ
(23, 34). It was proposed that this could be attributed to a form of sepsis, and subsequent ͵ͻʹ
death was caused by bacterial overload and was not due to specific virulence factors. Our ͵ͻ͵
data indicates that the threshold at which bacterial load triggers sepsis and death may vary ͵ͻͶ
from pathogen to pathogen.   ͵ͻͷ
Although the Drosophila model was used to determine virulence phenotypes of L. ͵ͻ͸
pneumophila mutants in the fly, further aspects underlying L. pneumophila pathogenesis in ͵ͻ͹
the insect have not been characterized (27). We show for the first time that L. pneumophila ͵ͻͺ
resides in a vacuole in haemocytes isolated from infected insects. This vacuole ͵ͻͻ
ultrastructurally resembled the LCV observed in human macrophages and amoeba, including ͶͲͲ
association of mitochondria, acquisition of a rough ER-like structure (1, 21) and recruitment ͶͲͳ
of SidC, which was previously shown to be tethered to the LCV via a phosphatidylinositol-4 ͶͲʹ
phosphate anchor (51). The recruitment of ribosomes and the T4SS-substrate SidC to the ͶͲ͵
haemocyte LCV suggests that L. pneumophila uses at least some of the fundamental ͶͲͶ
strategies which are employed to establish a replicative vacuole in mammalian cells and ͶͲͷ
amoeba also to infect insect haemocytes. ͶͲ͸
Analysis of L. pneumophila replication in G. mellonella by direct bacterial enumeration ͶͲ͹
demonstrated that, following an initial 10-fold reduction in CFU of wild type bacteria at 5 h ͶͲͺ
p.i., bacterial CFU quickly recovered and increased by 100-fold from the inoculum by 24 h ͶͲͻ
p.i. The ∆DotA mutant was cleared by 24 h p.i. The level of L. pneumophila replication ͶͳͲ
appears to be higher than in the mouse model, in which the strain 130b could exhibit up to 20 Ͷͳͳ
fold increase of CFU within 48 h (6, 40) or in the Drosophila model in which an increase of Ͷͳʹ
 ͳͻ
CFU up to 20 fold within 10 days was reported (27). The importance of bacterial persistence Ͷͳ͵
for L. pneumophila virulence in the G. mellonella model is demonstrated by the fact that L. ͶͳͶ
pneumophila strain Lp02, which did not persist after 18 h p.i. was unable to kill G. mellonella Ͷͳͷ
despite having a functional T4SS and forming a LCV in haemocytes. Moreover, the 130b Ͷͳ͸
strain, which replicated better in the larvae than the JR32 strain, induced death more rapidly Ͷͳ͹
than the JR32 strain, suggesting that in addition to persistence, bacterial replication also Ͷͳͺ
contributes to L. pneumophila virulence in the G. mellonella model. Ͷͳͻ
These data suggest a scenario in which immune cells successfully clear a fraction of the ͶʹͲ
inoculated L. pneumophila at early stages of infection. However, enough wild type bacteria Ͷʹͳ
evade destruction by phagocytes and start replicating. Release from haemocytes following Ͷʹʹ
replication is most likely accompanied with destruction of the haemocytes. This model is Ͷʹ͵
supported by the fact that 90% of the haemocytes are lost by 18 h p.i. following wild type L. ͶʹͶ
pneumophila infection. Depletion of circulating haemocytes upon bacterial infection has Ͷʹͷ
previously been reported and correlated with G. mellonella mortality caused by pathogenic Ͷʹ͸
fungi and Gram-negative bacteria (9, 34). This loss may be due to the death of infected Ͷʹ͹
haemocytes or the sequestration of haemocytes in nodules or a combination of both. However, Ͷʹͺ
nodules were observed in wild type and ∆DotA infected G. mellonella and there was no Ͷʹͻ
significant loss of haemocytes in ∆DotA infected larvae, suggesting that replication and Ͷ͵Ͳ
T4SS-dependent toxicity are the most likely cause of the loss of cells. Ͷ͵ͳ
Depletion of haemocytes, the major source of pro-phenoloxidase (pro-PO) which triggers the Ͷ͵ʹ
melanisation response upon infection, would also explain why we observed an initial Ͷ͵͵
activation of PO which was followed by a sharp drop at 18 h post infection. An alternative Ͷ͵Ͷ
hypothesis is that L. pneumophila may also specifically reduce PO activity; indeed, the insect Ͷ͵ͷ
pathogen Photorhabdus luminescens can inhibit PO activity at 18 h post infection (15). In Ͷ͵͸
conclusion, we demonstrate that G. mellonella is susceptible to L. pneumophila infection and Ͷ͵͹
 ʹͲ
that this model reproduces virulence phenotypes observed in amoeba and mammalian Ͷ͵ͺ
infection models. Virulence depends on the Dot/Icm T4SS and bacteria seem to reside and Ͷ͵ͻ
replicate in a typical LCV. Future advances in our knowledge about the G. mellonella ͶͶͲ
immune gene repertoire (50)  cell death pathways (25) and haemocyte biology (28, 30) ͶͶͳ
together with initiatives to advance RNA interference systems in Lepidoptera spp. (49) will ͶͶʹ
further increase the value of G. mellonella as an infection model which could potentially be ͶͶ͵
used to study the role of Dot/Icm T4SS effectors, the T2SS and other factors in virulence of ͶͶͶ
Legionella spp. ͶͶͷ
 ʹͳ
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Table 1 ͸ʹʹ
Primer  Sequence 
Gallerimycin FW GAAGATCGCTTTCATAGTCGC 
Gallerimycin RV TACTCCCTGCAGTTAGCAATGC 
Prophenoloxidase FW CCGCGAACACCGATCATCATTCCAAG 
Prophenoloxidase  RV GTGCACGCTTCCGTAGAGTTCCCGG 
Gloverin FW CGGTAGTCGGGTGTTGAGCCCGTATG 
Gloverin RV CGTCTGATACGATCGTAGGTGCC 
Peptidoglycan recognition protein B FW GGTCATCATCCAGCATACAGTGACG 
Peptidoglycan recognition protein B RV CCATCCAGTTGGGCCAGCTTCTTAT 
Transferrin FW CCCGAAGATGAACGATCAC 
Transferrin RV CGAAAGGCCTAGAACGTTTG 
Galliomicin FW CCTCTGA TTGCAA TGCTGAGTG 
Galliomicin RV GCTGCCAAGTTAGTCAACAGG 
Actin FW GGGACGATATGGAGAAG 
Actin RV CACGCTCTGTGAGGATCT 
All sequences from (24) 
 ͵Ͳ
Figure Legends ͸ʹ͵
Figure 1. L. pneumophila infection of Galleria mellonella induces dose- and Dot/Icm ͸ʹͶ
T4SS-dependent lethality. G. mellonella larvae were injected with PBS or L. pneumophila ͸ʹͷ
strain 130b, Paris or JR32 (107 CFU per larvae, if not otherwise indicated) and survival was ͸ʹ͸
monitored over 72 h p.i. (A) All three strains caused time-dependent death of the infected ͸ʹ͹
larvae, with strain 130b inducing significantly higher (P<0.005) mortality at 18 h p.i. (B) ͸ʹͺ
Mortality of the larvae upon infection with L. pneumophila strain 130b was dose-dependent. ͸ʹͻ
(C) Larvae survival was dependent on the growth phase of L. pneumophila. Larvae were ͸͵Ͳ
inoculated with L. pneumophila 130b cultured to exponential (E), post exponential (PE) or ͸͵ͳ
stationary (S) phase. Bacteria in post exponential phase demonstrated significantly (P<0.005) ͸͵ʹ
higher toxicity than bacteria in other growth phases at 18h p.i. (D) L. pneumophila-induced ͸͵͵
mortality in G. mellonella was dependent on the Dot/Icm T4SS. G. mellonella were injected ͸͵Ͷ
with L. pneumophila 130b wild type or T4SS-deficient strain ǻDotA. The T4SS mutant did ͸͵ͷ
not induce any mortality in the larvae 72 h p.i. Results represent the mean of at least three ͸͵͸
independent experiments ± standard deviations with 10 larvae per condition. ͸͵͹
 ͸͵ͺ
Figure 2. L. pneumophila is able to persist and replicate in G. mellonella. Haemolymph ͸͵ͻ
from three L. pneumophila-infected G. mellonella was extracted and the CFU/100µl were ͸ͶͲ
quantified. (A) Wild type L. pneumophila 130b replicated within the larvae over the infection ͸Ͷͳ
course, while the ǻDotA mutant was cleared from G. mellonella by 24 h p.i. (B) L. ͸Ͷʹ
pneumophila 130b invades and replicates within haemocytes. External and total bacteria were ͸Ͷ͵
immuno-stained. By 5 h p.i. both wild type and ǻDotA bacteria were found inside cells. By ͸ͶͶ
24 h p.i., wild type infected haemocytes had high loads of intracellular bacteria. (C and D) G. ͸Ͷͷ
mellonella mortality depends on L. pneumophila persistence. G. mellonella was inoculated ͸Ͷ͸
with L. pneumophila strains JR32, JR32 ǻIcmT or Lp02. (C) While the JR32 ǻIcmT strain ͸Ͷ͹
 ͵ͳ
was rapidly killed, the thymine auxotroph strain Lp02 declined slowly until 18 h p.i., before ͸Ͷͺ
being cleared until 24 h p.i. JR32 persisted at higher level throughout the course of infection. ͸Ͷͻ
(D) Only the wild type JR32 strain, but neither the ǻIcmT nor Lp02 strain induced mortality ͸ͷͲ
in G. mellonella by 72 h p.i. Results are representative of at least two independent ͸ͷͳ
experiments. ͸ͷʹ
 ͸ͷ͵
Figure 3. L. pneumophila forms a LCV in G. mellonella haemocytes. Haemocytes from G. ͸ͷͶ
mellonella infected with L. pneumophila 130b were extracted 5, 12 and 24 h p.i. and imaged ͸ͷͷ
by transmission electron microscopy. (A) At 5 h p.i., a few bacteria could be observed in ͸ͷ͸
distinct vacuoles within haemocytes. As the infection progressed, more bacteria per vacuole ͸ͷ͹
were found, until cells appeared filled with bacteria by 24 h p.i. Scale bar represents 2 µm (B) ͸ͷͺ
At 5 h p.i., mitochondria (arrowheads), ribosomes (arrows) and ribosome-associated vesicles ͸ͷͻ
were observed on the surface of the LCV. By 24 h p.i. the LCV was studded with ribosomes ͸͸Ͳ
(arrows). Scale bar represents 500 nm.  ͸͸ͳ
 ͸͸ʹ
Figure 4. SidC is localized to the LCV in haemocytes of infected G. mellonella. G. ͸͸͵
mellonella larvae were injected with L. pneumophila strains 130b, JR32 or Lp02 ͸͸Ͷ
overexpressing 4HA-SidC41-918. At 5 and 24 h p.i., haemocytes were extracted, fixed and ͸͸ͷ
stained with anti-HA antibody. By 5 h p.i. anti-HA staining revealed that SidC41-918 was ͸͸͸
localized on the LCV surface in haemocytes extracted from G. mellonella infected with wild ͸͸͹
type L. pneumophila strains but not 130b ǻDotA. By 24 h p.i., haemocytes from G. ͸͸ͺ
mellonella infected with 130b or JR32 were full of bacteria surrounded by 4HA-SidC41-918. In ͸͸ͻ
contrast, far fewer bacteria were observed in haemocytes from Galleria infected with strain ͸͹Ͳ
Lp02. Scale bar represents 5 µm. ͸͹ͳ
 ͸͹ʹ
 ͵ʹ
Figure 5. L. pneumophila infection of G. mellonella initiates a robust innate immune ͸͹͵
response. G. mellonella larvae were injected with L. pneumophila 130b, fixed and paraffin ͸͹Ͷ
embedded sections were stained with H&E. Uninfected G. mellonella appeared healthy with ͸͹ͷ
some occasional loose aggregations of haemocytes (A). At 16 h p.i. with wild type bacteria a ͸͹͸
number of nodules (N) could be observed with evidence of melanisation (arrows). At 16 h p.i. ͸͹͹
with ǻDotA some nodules were visible but by 24 h p.i., the larvae appeared similar to the ͸͹ͺ
uninfected control. At 24 h p.i. with the wild type bacteria, some nodules were still visible ͸͹ͻ
but a large number of L. pneumophila were visible in the haemcoel (B).  ͸ͺͲ
 ͸ͺͳ
Figure 6. Indirect immunofluorescence microscopy of formalin fixed sections of L. ͸ͺʹ
pneumophila infected G. mellonella. G. mellonella larvae were infected with L. ͸ͺ͵
pneumophila 130b for 18 h, fixed and paraffin embedded sections were stained using a ͸ͺͶ
specific anti-L. pneumophila antibody, DAPI was used to visualize bacterial and eukaryotic ͸ͺͷ
cell DNA and phalloidin to counter stain the tissue. No L. pneumophila staining was ͸ͺ͸
observed in the uninfected or ǻDotA controls. G. mellonella infected with wild type L. ͸ͺ͹
pneumophila demonstrated a systemic infection with large numbers of bacteria in the ͸ͺͺ
haemolymph. Bacteria were usually associated with cells (arrowheads), a proportion of which ͸ͺͻ
displayed apoptotic nuclei (arrows). Scale bar represents 20 µm. ͸ͻͲ
 ͸ͻͳ
Figure 7. Characterization of the G. mellonella innate immune response to L. ͸ͻʹ
pneumophila infection. G. mellonella larvae were infected with L. pneumophila 130b. (A) ͸ͻ͵
Larvae and extracted haemolymph became progressively darker over the course of the ͸ͻͶ
infection, indicative of melanin production by phenoloxidase (PO). (B) PO activity was ͸ͻͷ
quantified in the plasma of infected Galleria at 5 and 18 h p.i. In larvae infected with wild ͸ͻ͸
type L pneumophila, PO activity increased dramatically at 5 h p.i. and was almost abolished ͸ͻ͹
 ͵͵
at 18 h p.i. (C) Haemocyte concentration was recorded at 5 and 18 h p.i. with L. pneumophila ͸ͻͺ
130b. Infection with wild type bacteria resulted in ~ 90% reduction in haemocyte ͸ͻͻ
concentration after 18 h of infection. Results represent the mean of three independent ͹ͲͲ
experiments ± standard deviations with three larvae per condition. *** P<0.005. ͹Ͳͳ
 ͹Ͳʹ
Figure 8. L. pneumophila infection of G. mellonella up-regulates the expression of ͹Ͳ͵
antimicrobial peptides. Larvae were injected with PBS, wild type L. pneumophila 130b, or ͹ͲͶ
ǻDotA. Fat bodies of three infected G. mellonella were harvested and pooled at indicated ͹Ͳͷ
time points. Semi-quantitative RT-PCR was performed and the results were normalized to ͹Ͳ͸
actin mRNA expression. Larvae infected with wild type bacteria demonstrated increased ͹Ͳ͹
expression of antimicrobial peptides. Results are the mean of three independent experiments ͹Ͳͺ
± standard deviation. ͹Ͳͻ
 ͹ͳͲ








